Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Fage, Bruce A ^a   Chan, Calvin C H ^b   Gill, Sudeep S ^c   Noel Storr, Anna H ^d   Herrmann, Nathan ^a   Smailagic, Nadja ^e   Nikolaou, Vasilis ^f   Seitz, Dallas P ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Research in Real Life   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; COGNITIVE DEFECT; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MINI COG ASSESSMENT; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLICATION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SCREENING TEST; SECONDARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STUDY DESIGN; SYSTEMATIC REVIEW; AGED; DEMENTIA; NEUROPSYCHOLOGICAL TEST; SHORT TERM MEMORY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; DEMENTIA; HUMANS; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84934301160     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010860.pub2     Document Type: Review

References (66)

1. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The Mini-Cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. International Journal of Geriatric Psychiatry 2000;15:1021-7.
2. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. Journal of the American Geriatrics Society 2003;51:1451-4.
3. Borson S, Scanlan J, Watanabe J, Tu SP, Lessig M. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini Mental State Examination in a multiethnic sample. Journal of the American Geriatrics Society 2005;53:871-4.
4. Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Improving identification of cognitive impairment in primary care. International Journal of Geriatric Psychiatry 2006;21:349-55.
5. Costa D, Severo M, Fraga S, Barros H. Mini-Cog and Mini-Mental State Examination: agreement in a cross-sectional study with an elderly sample. Dementia and Geriatric Cognitive Disorders 2012;33:118-24.
6. Lorentz W, Borson SJ. Informant questions improve Mini-Cog discrimination of mild cognitive impairment. Journal of Investigative Medicine 2003;51.
7. Scalan JM, Borson S, Binkin N, Michieletto F. Mini-Cog associations with functional disability and education in an Italian sample. Journal of the American Geriatrics Society 2004;52(4):S98-9.
8. Scanlan JM, Binkin N, Michieletto F, Lessig M, Zuhr E, Borson S. Cognitive impairment, chronic disease burden, and functional disability: a population study of older italians. American Journal of Geriatric Psychiatry 2007;15(8):716-24.
9. Tappen RM, Rosselli M, Engstrom G. Evaluation of the Functional Activities Questionnaire (FAQ) in cognitive screening across four American ethnic groups. The Clinical Neuropsychologist 2010;24:646-61.
10. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Movement Disorders 2005;20:1255-63.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington (DC): American Psychiatric Association, 2000.
12. Bennett P, Leifer MD. Early diagnosis of Alzheimer's disease: clinical and economic benefits. Journal of the American Geriatrics Society 2003;51(5):S281-8.
13. Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, Glanville JM. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE. Cochrane Database of Systematic Reviews 2013, (9):Art. No.: MR000022.
14. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005593]
15. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006;368:387-403.
16. Borson S, Scanlan J, Watanabe J, Tu S-P, Lessig M. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. Journal of the American Geriatrics Society 2005;53:871-4.
17. Boustani M, Callahan CM, Unverzagt FW, Austrom MG, Perkins AJ, Fultz BA, et al.Implementing a screening and diagnosis program for dementia in primary care. Journal of General Internal Medicine 2005;20:572-7.
18. Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA. The GPCOG: a new screening test for dementia designed for general practice. Journal of the American Geriatrics Society 2002;50:530-4.
19. Brodaty H, Lee-Fay L, Gibson L, Burns K. What is the best dementia screening instrument for general practitioners to use?. American Journal of Geriatric Psychiatry 2006;14:391-400.
20. Brunnström H, Gustafson L, Passant U, Englund E. Prevalence of dementia subtypes: a 30-year retrospective study of neuropathological reports. Archives of Gerontology and Geriatrics 2009;49:146-9.
21. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, Lipton RB. Screening for dementia with the memory impairment screen. Neurology 1999;52:231-8.
22. Cordell CB, Borson S, Reuben D, Verghese J, Thies W, Fried LB, Medicare Detection of Cognitive Impairment Workgroup. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimer's & Dementia 2013;9:141-50.
23. Creavin ST, Noel-Storr A, Smailagic N, Giannakou A, Ewins E, Wisniewski S, Cullum S. Mini-Mental State Examination for the detection of Alzheimer's dementia and other dementias in asymptomatic and previously clinically unevaluated people over 65 years in community and primary care populations. Cochrane Database of Systematic Reviews 2014, Issue June 10. [DOI: 10.1002/14651858.CD011145]
24. Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Archives of Neurology 2000;57:713-9.
25. Canadian Study of Health and Aging. Canadian study of health and aging: study methods and prevalence of dementia. Canadian Medical Association Journal 1994;150:899-913.
26. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 2005;58:882-93.
27. Feldman H, Levey AR, Hsiung GY, Peters KR, Donald A, Black SE, et al.A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 2003;22(5):265-74.
28. Feldman H, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, et al.Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal 2008;178(7):825-36.
29. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 2005;331(7524):1064-5.
30. Greicius MD, Geschwind MD, Miller BL. Presenile dementia syndromes: an update on taxonomy and diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry 2002;72:691-700.
31. Harris DP, Chodosh J, Vassar SD, Vickrey BG, Shapiro MF. Primary care providers' views of challenges and rewards of dementia care relative to other conditions. Journal of the American Geriatrics Society 2009;57:2209-16.
32. Harrison JK, Fearon P, Noel-Storr A, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia in general practice (primary care) setting. Cochrane Database of Systematic Reviews 2014, Issue July 3. [DOI: 10.1002/14651858.CD010771.pub2]
33. Hebert LE, Scherr PA, Bienias JL, Bennet DA, Evans DA. Alzheimer disease in the U.S. population: prevalence estimates using the 2000 census. Archives of Neurology 2003;60:1119-22.
34. Hendry K, Lees R, McShane R, Noel-Storr A, Stott DJ, Quinn TJ. AD-8 for diagnosis of dementia across a variety of healthcare settings. Cochrane Database of Systematic Reviews 2014, Issue May 19. [DOI: 10.1002/14651858.CD011121]
35. Holsinger T, Deveau J, Boustani M, Williams J. Does this patient have dementia?. JAMA 2007;297(21):2391-404.
36. Horsely T, Dingwall O, Sampson M. Checking reference lists to find additional studies for systematic reviews. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.MR000026.pub2]
37. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. http://www.who.int/classifications/icd/en/ 2010.
38. Knopman D, DeKosky S, Cummings J, Chui H, Corey-Bloom J, Relkin N, et al.Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-53.
39. Lin JS, O'Connor E, Rossum RC, Perdue LA, Eckstrom E. Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2013;159(9):601-12.
40. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al.Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 2000;54 Suppl 5:S4-S9.
41. Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Analysing and presenting results. Handbook for Systematic Reviews of Diagnostic Test Accuracy. Vol. 1.0, The Cochrane Collaboration, 2010.
42. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, Brayne C, Medical Research Council Cogntive Function and Ageing Collaboration. A two-decade comparison of dementia in individuals aged 65 years and older from three geographic areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013;382(9902):1405-12.
43. McCarten JR, Anderson P, Kuskowski MA, McPherson SE, Borson S. Screening for cognitive impairment in an elderly veteran population: acceptability and results using different versions of the Mini-Cog. Journal of the American Geriatrics Society 2011;59:309-13.
44. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al.Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72.
45. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Neurology 1984;34:939-44.
46. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, et al.Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Archives of Neurology 2001;58:1803-9.
47. McKhann G, Knopman D, Chertkow H, Hyman B, Jack C, Kawas C, et al.The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:263-9.
48. McShane R, Sastre AA, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003154.pub5]
49. Nagy Z, Esiri MM, Hindley NJ, Joachim C, Morris JH, King EMF, et al.Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dementia and Geriatric Cognitive Disorders 1998;9:219-26.
50. Pimlott NJ, Persaud M, Drummond N, Cohen CA, Silvius JL, Seigel K, et al.Family physicians and dementia in Canada: Part 1. Clinical practice guidelines: awareness, attitudes and opinions. Canadian Family Physician 2009;55:508-9.
51. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & Dementia 2013;9:63-75.
52. Prorok JC, Horgan S, Seitz DP. Health care experiences of people with dementia and their caregivers: a meta-ethnographic analysis of qualitative studies. Canadian Medical Association Journal 2013;185(14):E669-80.
53. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58:982-90.
54. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
55. Rolinski I, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD006504.pub2]
56. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al.Vascular dementia: diagnostic criteria for research studies. Neurology 1993;43:250-60.
57. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20:2865-84.
58. Scanlan J, Borson S. The Mini-Cog: receiver operating characteristics with expert and naive raters. International Journal of Geriatric Psychiatry 2001;16:216-22.
59. Sternberg SA, Wolfson C, Baumgarten M. Undetected dementia in community-dwelling older people: the Canadian study of Health and Aging. Journal of the American Geriatrics Society 2000;40(11):1430-4.
60. Thies W, Bleiler L. 2012 Alzheimer's disease facts and figures. Alzheimer's & Dementia 2012;8:131-68.
61. van den Dungen P, van Marwijk H, van der Horst H, van Charante E, Vroomen J, van de Ven P, et al.The accuracy of family physicians' dementia diagnoses at different stages of dementia: a systematic review. International Journal of Geriatric Psychiatry 2011;27:342-54.
62. van Ernst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM. Investigation of publication bias in meta-analysis of diagnostic accuracy: a meta-epidemiological study. BMC Medical Research Methodology 2014;14:70.
63. Whiting P, Westwood M, Beynon R, Burke M, Sterne JAC, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64(6):602-7.
64. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al.QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36.
65. Wilkinson D. A review of the effects of memantine on clinical progression in Alzheimer's disease. International Journal of Geriatric Psychiatry 2012;27:769-76. [DOI: 10.1002/gps.2788]
66. Yaffe MJ, Orzeck P, Barylak L. Family physicians' perspectives on care of dementia patients and family caregivers. Canadian Family Physician 2008;54:1008-15.